🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Susan Chi

Boston Children's Hospital

ORCID: 0000-0001-7753-878X

Also affiliated with Dana-Farber Cancer Institute, Boston Children's Museum, Dana-Farber/Boston Children's Cancer and Blood Disorders Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.400Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer

Nature Communications(2024)10.1038/s41467-024-49944-0
Top 46%
0.400DataRank
Top 46%8 citations

Hersh Gupta, Abigail Ward, Yvonne Li, Duong Doan, Alyaa Al‐Ibraheemi +28 more

Papers

Driven by 12 papers — median percentile 54. Top paper: “Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma”.

Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma

Journal of Clinical Investigation(2020)10.1172/jci140378
N/A
2.8DataRank · unranked
120 citations

Jared Taitt, Javier Villanueva-Meyer, Erin R. Bonner, Takahide Nejo, Rishi R. Lulla +18 more

Structural variants shape driver combinations and outcomes in pediatric high-grade glioma

Nature Cancer(2022)10.1038/s43018-022-00403-z
N/A
1.1DataRank · unranked
48 citations

Ofer Shapira, Noah F. Greenwald, Travis Zack, Jeremiah A. Wala, Jessica W. Tsai +35 more

Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad085
N/A
0.685DataRank · unranked
95 citations

Joanna S. Yi, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +17 more

Eps15 Mediates Vesicle Trafficking from thetrans-Golgi Network via an Interaction with the Clathrin Adaptor AP-1

Molecular Biology of the Cell(2008)10.1091/mbc.e07-10-0997
N/A
0.564DataRank · unranked
42 citations

Hong Cao, Jing Chen, Mark A. McNiven, Susan Chi

Tazemetostat in patients with tumors with alterations in EZH2 or the SWI/SNF complex: Results from NCI-COG Pediatric MATCH trial Arm C (APEC1621C).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10009
N/A
0.464DataRank · unranked
21 citations

Joanna S. Yi, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +15 more

ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-21-3521
N/A
0.449DataRank · unranked
19 citations

Ross Giglio, Maya Srikanth Graham, Guadalupe Garcia, Seth Malinowski, Jared K. Woods +41 more

Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer

Nature Communications(2024)10.1038/s41467-024-49944-0
Top 46%
0.400DataRank
Top 46%8 citations

Hersh Gupta, Abigail Ward, Yvonne Li, Duong Doan, Alyaa Al‐Ibraheemi +28 more

DICER1 mutations in primary central nervous system tumors: new insights into histologies, mutations, and prognosis

Journal of Neuro-Oncology(2022)10.1007/s11060-022-03994-w
N/A
0.356DataRank · unranked
5 citations

Helen H. Shang, Chantel Cacciotti, Emily Everdell, Ayal A. Aizer, Rifaquat Rahman +11 more

A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1–associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study

Neuro-Oncology(2020)10.1093/neuonc/noaa071
N/A
0DataRank · unranked
82 citations

Sanjay P. Prabhu, Alyssa Reddy, Michael J. Fisher, Roger J. Packer, Stewart Goldman +15 more

Paediatric strategy forum for medicinal product development of cyclin-dependent kinase inhibitors in children and adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration

European Journal of Cancer(2025)10.1016/j.ejca.2025.115629
N/A
0DataRank · unranked
4 citations

Susan Chi, Theodore W Laetscht, Lynley V. Marshall, Elizabeth A. Raetz, Rani E. George +34 more

H3K27M- and BRAF V600E -Altered gliomas and glioneuronal tumors—clinico-pathologic and radiologic perspective in a cohort treated with targeted therapy

Neuro-Oncology Advances(2025)10.1093/noajnl/vdaf197
N/A
0DataRank · unranked
0 citations

Vanessa Rameh, Tom Rosenberg, Kee Kiat Yeo, Susan Chi, Karen Wright +8 more

LGG-13. RESOLVING TRANSCRIPTIONAL PROFILES IN BRAF-REARRANGED PILOCYTIC ASTROCYTOMA USING SINGLE CELL RNA SEQUENCING

Neuro-Oncology(2018)10.1093/neuonc/noy059.355
N/A
0DataRank · unranked
0 citations

Guillaume Bergthold, Kristine Pelton, Sarah Becker, Robert Jones, Zach Herbert +16 more